Prof Schmidt receives grant from BAYER
Prof. Martina Schmidt of the Groningen Research Institute of Pharmacy ( GRIP ) has been awarded a grant of the company BAYER GmbH. The grant worth EUR 175,000 is for her research project ‘ Evaluation of the P2RX4 antagonist BR11595 in experimental guinea pig models of allergen-induced acute and chronic asthma and ATP/citric acid-induced cough’. Schmidt conducts this project together with Prof. Reinoud Gosens and Dr. Loes Kistemaker.
Asthma is a common chronic lung disease, affecting over 300 million people worldwide. Patients with asthma suffer from airway obstruction and reduced bronchodilation by deep breathing due to remodeling of the bronchial tree. Episodes with worsening of particularly severe asthma (so-called exacerbations), in addition to airway obstruction, are often characterized by coughing. In the current studies, the researchers will investigate the potential of the P2X4 purinergic ion channel receptor as a novel anti-asthma drug, targeting airway obstruction and in particular cough.
The goal is to develop in vivo cough models in guinea pigs to investigate an intervention strategy taking place when the exacerbation and the burden of coughing is maximal. By combining this with classical asthma models investigating effects on lung function, airway remodeling and airway inflammation, the researchers aim to elucidate the potential of the novel P2RX4 antagonist in asthma and thereby contribute to improved therapy for (severe) asthma patients.

Last modified: | 17 November 2020 10.45 a.m. |
More news
-
17 July 2025
Veni-grants for eleven UG researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...
-
14 July 2025
ERC Proof of Concept grant for Kottapalli and Covi
Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).
-
10 July 2025
Dutch Research Agenda funding for nanomedicine research
Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.